B · Normal
[Liraglutide Injection of Chen'an Biopharmaceutical Co., Ltd., a subsidiary of Zhifei Biotechnology, was officially put into clinical use] September 11th, according to Zhifei Biotechnology, recently, liraglutide injection (trade name: Dashuchen®) independently developed and produced by Chongqing Chenan Biopharmaceutical Co., Ltd., a subsidiary of Zhifei Biotechnology, completed the first injection in the country at Banan Hospital Affiliated to Chongqing Medical University (Chongqing Banan District People's Hospital). The clinical use of Liraglutide Injection Dashuchen® provides a new domestic drug option for the standardized treatment of diabetic patients.
Comments